Tapewire

Nasdaq · USD

NTRA

Natera, Inc.

Export transactions ↓
Tapewire entity
2635
SEC CIK
0001604821
Parsed reports
1,197

Last 12 months

Inside the activity.

0 purchase rows · 457 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025047
Dec 2025021
Jan 2026041
Feb 2026021
Mar 2026054
Apr 2026029
May 2026033
Jun 2026068
Jul 2026047
Aug 2026033
Sep 2026059
Oct 202604

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 29, 2025 Filed Feb 1, 2025 02:35 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 1,053 $165.87 $174,659.74
Disclosure

SEC source: 0001415889-25-002626 · form4-01312025_090112.xml · nonDerivative · entry 1

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 260,104

F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 26, 2024.

Read SEC document
January 29, 2025 Filed Feb 1, 2025 02:35 UTC
Rabinowitz MatthewDirector · EXECUTIVE CHAIRMAN
SaleCommon Stock 4 $167.36 $669.44
Disclosure

SEC source: 0001415889-25-002625 · form4-01312025_090110.xml · nonDerivative · entry 2

Rabinowitz Matthew · CIK 0001646382 · Director · EXECUTIVE CHAIRMAN

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,383,177

F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 26, 2024.

Read SEC document
January 29, 2025 Filed Feb 1, 2025 02:35 UTC
Rabinowitz MatthewDirector · EXECUTIVE CHAIRMAN
SaleCommon Stock 5,999 $165.87 $995,046.33
Disclosure

SEC source: 0001415889-25-002625 · form4-01312025_090110.xml · nonDerivative · entry 1

Rabinowitz Matthew · CIK 0001646382 · Director · EXECUTIVE CHAIRMAN

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,383,181

F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 26, 2024.

Read SEC document
January 29, 2025 Filed Feb 1, 2025 02:35 UTC
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
SaleCommon Stock 2 $167.20 $334.40
Disclosure

SEC source: 0001415889-25-002624 · form4-01312025_090108.xml · nonDerivative · entry 3

RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 213,020

F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 26, 2024.

Read SEC document
January 29, 2025 Filed Feb 1, 2025 02:35 UTC
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
SaleCommon Stock 3,730 $165.87 $618,690.25
Disclosure

SEC source: 0001415889-25-002624 · form4-01312025_090108.xml · nonDerivative · entry 2

RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 213,022

F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 26, 2024.

Read SEC document
January 29, 2025 Filed Feb 1, 2025 02:35 UTC
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
SaleCommon Stock 1,041 $165.87 $172,669.32
Disclosure

SEC source: 0001415889-25-002624 · form4-01312025_090108.xml · nonDerivative · entry 1

RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 216,752

F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 27, 2023.

Read SEC document
January 27, 2025 Filed Jan 30, 2025 02:45 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
SaleCommon Stock 1,442 $161.87 $233,416.54
Disclosure

SEC source: 0001415889-25-002325 · form4-01292025_090101.xml · nonDerivative · entry 1

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 108,032

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023.

Read SEC document
January 27, 2025 Filed Jan 30, 2025 02:45 UTC
Sheena JonathanDirector · CO-FOUNDER
GiftCommon Stock 588 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-002326 · form4-01292025_090104.xml · nonDerivative · entry 1

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 261,157

F1 · shares: Represents a charitable contribution by the Reporting Person.

Read SEC document
January 24, 2025 Filed Jan 25, 2025 02:45 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
SaleCommon Stock 259 $172.44 $44,662.09
Disclosure

SEC source: 0001415889-25-002083 · form4-01242025_090106.xml · nonDerivative · entry 4

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 109,474

F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023.

Read SEC document
January 24, 2025 Filed Jan 25, 2025 02:45 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
SaleCommon Stock 687 $171.80 $118,026.60
Disclosure

SEC source: 0001415889-25-002083 · form4-01242025_090106.xml · nonDerivative · entry 3

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 109,733

F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2023.

Read SEC document
January 23, 2025 Filed Jan 25, 2025 02:45 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
SaleCommon Stock 495 $171.09 $84,689.55
Disclosure

SEC source: 0001415889-25-002083 · form4-01242025_090106.xml · nonDerivative · entry 2

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 110,420

F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on October 22, 2021.

Read SEC document
January 22, 2025 Filed Jan 23, 2025 02:45 UTC
Chapman Steven LeonardDirector · CEO AND PRESIDENT
SaleCommon Stock 194 $171.97 $33,362.01
Disclosure

SEC source: 0001415889-25-001894 · form4-01222025_090104.xml · nonDerivative · entry 4

Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 267,629

F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021, January 28, 2022, and January 27, 2023.

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.8937 to $172.0100 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 22, 2025 Filed Jan 23, 2025 02:45 UTC
Chapman Steven LeonardDirector · CEO AND PRESIDENT
SaleCommon Stock 78,359 $164.95 $12,925,223.02
Disclosure

SEC source: 0001415889-25-001894 · form4-01222025_090104.xml · nonDerivative · entry 3

Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 267,823

F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021, January 28, 2022, and January 27, 2023.

Read SEC document
January 22, 2025 Filed Jan 23, 2025 02:45 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
SaleCommon Stock 64 $171.95 $11,004.54
Disclosure

SEC source: 0001415889-25-001893 · form4-01222025_090101.xml · nonDerivative · entry 4

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 109,665

F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021, January 28, 2022, and January 27, 2023.

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.90 to $171.97 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 22, 2025 Filed Jan 23, 2025 02:45 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
SaleCommon Stock 25,867 $164.95 $4,266,730.61
Disclosure

SEC source: 0001415889-25-001893 · form4-01222025_090101.xml · nonDerivative · entry 3

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 109,729

F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021, January 28, 2022, and January 27, 2023.

Read SEC document
January 22, 2025 Filed Jan 23, 2025 02:45 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 7 $171.91 $1,203.36
Disclosure

SEC source: 0001415889-25-001896 · form4-01222025_090109.xml · nonDerivative · entry 4

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 261,745

F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021, January 28, 2022, and January 27, 2023.

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.90 to $171.9160 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 22, 2025 Filed Jan 23, 2025 02:45 UTC
Sheena JonathanDirector · CO-FOUNDER
SaleCommon Stock 964 $164.95 $159,010.64
Disclosure

SEC source: 0001415889-25-001896 · form4-01222025_090109.xml · nonDerivative · entry 3

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 261,752

F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021, January 28, 2022, and January 27, 2023.

Read SEC document
January 22, 2025 Filed Jan 23, 2025 02:45 UTC
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
SaleCommon Stock 54 $171.95 $9,285.19
Disclosure

SEC source: 0001415889-25-001895 · form4-01222025_090107.xml · nonDerivative · entry 4

RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 217,793

F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021, January 28, 2022, and January 27, 2023.

F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.9347 to $171.9700 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 22, 2025 Filed Jan 23, 2025 02:45 UTC
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
SaleCommon Stock 21,985 $164.95 $3,626,399.37
Disclosure

SEC source: 0001415889-25-001895 · form4-01222025_090107.xml · nonDerivative · entry 3

RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 217,847

F2 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021, January 28, 2022, and January 27, 2023.

Read SEC document
January 22, 2025 Filed Jan 25, 2025 02:45 UTC
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
SaleCommon Stock 53 $171.96 $9,113.97
Disclosure

SEC source: 0001415889-25-002081 · form4-01242025_090101.xml · nonDerivative · entry 2

Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 147,230

F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021, January 28, 2022, June 10, 2022, and January 27, 2023.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.9160 to $171.9700 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 22, 2025 Filed Jan 25, 2025 02:45 UTC
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
SaleCommon Stock 21,175 $164.95 $3,492,790.84
Disclosure

SEC source: 0001415889-25-002081 · form4-01242025_090101.xml · nonDerivative · entry 1

Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 147,283

F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021, January 28, 2022, June 10, 2022, and January 27, 2023.

Read SEC document
January 22, 2025 Filed Jan 25, 2025 02:45 UTC
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
SaleCommon Stock 62 $171.95 $10,661.16
Disclosure

SEC source: 0001415889-25-002082 · form4-01242025_090103.xml · nonDerivative · entry 2

Moshkevich Solomon · CIK 0002010019 · PRESIDENT, CLINICALDIAGNOSTICS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 140,684

F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021, January 28, 2022, June 10, 2022, and January 27, 2023.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.90 to $171.97 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 22, 2025 Filed Jan 25, 2025 02:45 UTC
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
SaleCommon Stock 24,799 $164.95 $4,090,565.29
Disclosure

SEC source: 0001415889-25-002082 · form4-01242025_090103.xml · nonDerivative · entry 1

Moshkevich Solomon · CIK 0002010019 · PRESIDENT, CLINICALDIAGNOSTICS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 140,746

F1 · shares: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021, January 28, 2022, June 10, 2022, and January 27, 2023.

Read SEC document
January 22, 2025 Filed Jan 25, 2025 02:45 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 1,250 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-002083 · form4-01242025_090106.xml · derivative · entry 5

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,750

Underlying: Common Stock · 1,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: The RSUs vest over four years. 25% of the RSUs vested on October 22, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter.

F4 · derivative.expiration_date: The RSUs vest over four years. 25% of the RSUs vested on October 22, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter.

Read SEC document
January 22, 2025 Filed Jan 25, 2025 02:45 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 1,250 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-002083 · form4-01242025_090106.xml · nonDerivative · entry 1

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 110,915

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
January 21, 2025 Filed Jan 23, 2025 02:45 UTC
Chapman Steven LeonardDirector · CEO AND PRESIDENT
Exercise / conversionRestricted Stock Unit · Derivative 1,775 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001894 · form4-01222025_090104.xml · derivative · entry 6

Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,775 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F5 · derivative.exercise_date: The RSUs vest over four years. 25% of the RSUs vested on January 21, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter.

F5 · derivative.expiration_date: The RSUs vest over four years. 25% of the RSUs vested on January 21, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter.

Read SEC document
January 21, 2025 Filed Jan 23, 2025 02:45 UTC
Chapman Steven LeonardDirector · CEO AND PRESIDENT
Exercise / conversionCommon Stock 1,775 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-001894 · form4-01222025_090104.xml · nonDerivative · entry 2

Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 346,182

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
January 21, 2025 Filed Jan 23, 2025 02:45 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 1,145 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001893 · form4-01222025_090101.xml · derivative · entry 6

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,145 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F5 · derivative.exercise_date: The RSUs vest over four years. 25% of the RSUs vested on January 21, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter.

F5 · derivative.expiration_date: The RSUs vest over four years. 25% of the RSUs vested on January 21, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter.

Read SEC document
January 21, 2025 Filed Jan 23, 2025 02:45 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 1,145 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-001893 · form4-01222025_090101.xml · nonDerivative · entry 2

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 135,596

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
January 21, 2025 Filed Jan 23, 2025 02:45 UTC
Sheena JonathanDirector · CO-FOUNDER
Exercise / conversionRestricted Stock Unit · Derivative 144 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001896 · form4-01222025_090109.xml · derivative · entry 8

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 144 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F6 · derivative.exercise_date: The RSUs vest over four years. 25% of the RSUs vested on January 21, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter

F6 · derivative.expiration_date: The RSUs vest over four years. 25% of the RSUs vested on January 21, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter

Read SEC document
January 21, 2025 Filed Jan 23, 2025 02:45 UTC
Sheena JonathanDirector · CO-FOUNDER
Exercise / conversionCommon Stock 144 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-001896 · form4-01222025_090109.xml · nonDerivative · entry 2

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 262,716

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
January 21, 2025 Filed Jan 23, 2025 02:45 UTC
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 644 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001895 · form4-01222025_090107.xml · derivative · entry 6

RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 644 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F5 · derivative.exercise_date: The RSUs vest over four years. 25% of the RSUs vested on January 21, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter.

F5 · derivative.expiration_date: The RSUs vest over four years. 25% of the RSUs vested on January 21, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter.

Read SEC document
January 21, 2025 Filed Jan 23, 2025 02:45 UTC
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
Exercise / conversionCommon Stock 644 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-001895 · form4-01222025_090107.xml · nonDerivative · entry 2

RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 239,832

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
January 20, 2025 Filed Jan 23, 2025 02:45 UTC
Chapman Steven LeonardDirector · CEO AND PRESIDENT
Exercise / conversionRestricted Stock Unit · Derivative 3,386 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001894 · form4-01222025_090104.xml · derivative · entry 5

Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,544

Underlying: Common Stock · 3,386 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: The RSUs vest over four years. 25% of the RSUs vested on January 20, 2023 and the remaining shares vest in 12 equal quarterly installments thereafter.

F4 · derivative.expiration_date: The RSUs vest over four years. 25% of the RSUs vested on January 20, 2023 and the remaining shares vest in 12 equal quarterly installments thereafter.

Read SEC document
January 20, 2025 Filed Jan 23, 2025 02:45 UTC
Chapman Steven LeonardDirector · CEO AND PRESIDENT
Exercise / conversionCommon Stock 3,386 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-001894 · form4-01222025_090104.xml · nonDerivative · entry 1

Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 344,407

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
January 20, 2025 Filed Jan 23, 2025 02:45 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 1,522 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001893 · form4-01222025_090101.xml · derivative · entry 5

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,087

Underlying: Common Stock · 1,522 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: The RSUs vest over four years. 25% of the RSUs vested on January 20, 2023 and the remaining shares vest in 12 equal quarterly installments thereafter.

F4 · derivative.expiration_date: The RSUs vest over four years. 25% of the RSUs vested on January 20, 2023 and the remaining shares vest in 12 equal quarterly installments thereafter.

Read SEC document
January 20, 2025 Filed Jan 23, 2025 02:45 UTC
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 1,522 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-001893 · form4-01222025_090101.xml · nonDerivative · entry 1

Brophy Michael Burkes · CIK 0001697362 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 134,451

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
January 20, 2025 Filed Jan 23, 2025 02:45 UTC
Sheena JonathanDirector · CO-FOUNDER
Exercise / conversionRestricted Stock Unit · Derivative 191 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001896 · form4-01222025_090109.xml · derivative · entry 7

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 761

Underlying: Common Stock · 191 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F5 · derivative.exercise_date: The RSUs vest over four years. 25% of the RSUs vested on January 20, 2023 and the remaining shares vest in 12 equal quarterly installments thereafter.

F5 · derivative.expiration_date: The RSUs vest over four years. 25% of the RSUs vested on January 20, 2023 and the remaining shares vest in 12 equal quarterly installments thereafter.

Read SEC document
January 20, 2025 Filed Jan 23, 2025 02:45 UTC
Sheena JonathanDirector · CO-FOUNDER
Exercise / conversionCommon Stock 191 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-001896 · form4-01222025_090109.xml · nonDerivative · entry 1

Sheena Jonathan · CIK 0001646649 · Director · CO-FOUNDER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 262,572

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
January 20, 2025 Filed Jan 23, 2025 02:45 UTC
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 856 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001895 · form4-01222025_090107.xml · derivative · entry 5

RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,424

Underlying: Common Stock · 856 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: The RSUs vest over four years. 25% of the RSUs vested on January 20, 2023 and the remaining shares vest in 12 equal quarterly installments thereafter.

F4 · derivative.expiration_date: The RSUs vest over four years. 25% of the RSUs vested on January 20, 2023 and the remaining shares vest in 12 equal quarterly installments thereafter.

Read SEC document
January 20, 2025 Filed Jan 23, 2025 02:45 UTC
RABINOWITZ DANIELSEC. AND CHIEF LEGAL OFFICER
Exercise / conversionCommon Stock 856 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-001895 · form4-01222025_090107.xml · nonDerivative · entry 1

RABINOWITZ DANIEL · CIK 0001857843 · SEC. AND CHIEF LEGAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 239,188

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
January 16, 2025 Filed Jan 22, 2025 02:45 UTC
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
GrantCommon Stock 10,822 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-001833 · form4-01212025_090105.xml · nonDerivative · entry 3

Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 168,458

F4 · shares: On June 10, 2022, the Reporting Person was granted a performance-based RSU award which vests in tranches upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. On January 16, 2025, the performance threshold with respect to one milestone under the RSUs was certified, resulting in the vesting of 10,822 shares of Common Stock.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria.

Read SEC document
January 16, 2025 Filed Jan 22, 2025 02:45 UTC
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
GrantCommon Stock 29,798 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-001833 · form4-01212025_090105.xml · nonDerivative · entry 2

Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 157,636

F3 · shares: On January 27, 2023, the Reporting Person was granted a performance-based RSU award which vests in tranches upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. On January 16, 2025, the performance threshold with respect to one milestone under the RSUs was certified, resulting in the vesting of 29,798 shares of Common Stock.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria.

Read SEC document
January 16, 2025 Filed Jan 22, 2025 02:45 UTC
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
GrantCommon Stock 13,696 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-001833 · form4-01212025_090105.xml · nonDerivative · entry 1

Fesko John · CIK 0002010135 · PRESIDENT, CHIEF BUS. OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 127,838

F1 · shares: On January 28, 2022, the Reporting Person was granted a performance-based Restricted Stock Unit ("RSU") award which vests upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. On January 16, 2025, the achievement of milestones was certified resulting in the vesting of all such RSUs.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria.

Read SEC document
January 16, 2025 Filed Jan 22, 2025 02:45 UTC
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
GrantCommon Stock 9,620 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-001834 · form4-01212025_090108.xml · nonDerivative · entry 3

Moshkevich Solomon · CIK 0002010019 · PRESIDENT, CLINICALDIAGNOSTICS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 165,545

F4 · shares: On June 10, 2022, the Reporting Person was granted a performance-based RSU award which vests in tranches upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. On January 16, 2025, the performance threshold with respect to one milestone under the RSUs was certified, resulting in the vesting of 9,620 shares of Common Stock.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria.

Read SEC document
January 16, 2025 Filed Jan 22, 2025 02:45 UTC
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
GrantCommon Stock 29,798 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-001834 · form4-01212025_090108.xml · nonDerivative · entry 2

Moshkevich Solomon · CIK 0002010019 · PRESIDENT, CLINICALDIAGNOSTICS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 155,925

F3 · shares: On January 27, 2023, the Reporting Person was granted a performance-based RSU award which vests in tranches upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. On January 16, 2025, the performance threshold with respect to one milestone under the RSUs was certified, resulting in the vesting of 29,798 shares of Common Stock.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria.

Read SEC document
January 16, 2025 Filed Jan 22, 2025 02:45 UTC
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
GrantCommon Stock 9,130 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-001834 · form4-01212025_090108.xml · nonDerivative · entry 1

Moshkevich Solomon · CIK 0002010019 · PRESIDENT, CLINICALDIAGNOSTICS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,127

F1 · shares: On January 28, 2022, the Reporting Person was granted a performance-based Restricted Stock Unit ("RSU") award which vests upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. On January 16, 2025, the achievement of milestones was certified resulting in the vesting of all such RSUs.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria.

Read SEC document
January 16, 2025 Filed Jan 22, 2025 02:45 UTC
Chapman Steven LeonardDirector · CEO AND PRESIDENT
Exercise / conversionRestricted Stock Unit · Derivative 54,175 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-001832 · form4-01212025_090103.xml · derivative · entry 3

Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 54,175 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria.

F3 · derivative.exercise_date: On January 28, 2022, the Reporting Person was granted a performance-based RSU award which vests upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. On January 16, 2025, the achievement of milestones was certified resulting in the vesting of all such RSUs.

F3 · derivative.expiration_date: On January 28, 2022, the Reporting Person was granted a performance-based RSU award which vests upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. On January 16, 2025, the achievement of milestones was certified resulting in the vesting of all such RSUs.

Read SEC document
January 16, 2025 Filed Jan 22, 2025 02:45 UTC
Chapman Steven LeonardDirector · CEO AND PRESIDENT
GrantCommon Stock 101,812 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-001832 · form4-01212025_090103.xml · nonDerivative · entry 2

Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 341,021

F2 · shares: On January 27, 2023, the Reporting Person was granted a performance-based RSU award which vests in tranches upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. On January 16, 2025, the performance threshold with respect to one milestone under the RSUs was certified, resulting in the vesting of 101,812 shares of Common Stock.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria.

Read SEC document
January 16, 2025 Filed Jan 22, 2025 02:45 UTC
Chapman Steven LeonardDirector · CEO AND PRESIDENT
Exercise / conversionCommon Stock 54,175 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-001832 · form4-01212025_090103.xml · nonDerivative · entry 1

Chapman Steven Leonard · CIK 0001711968 · Director · CEO AND PRESIDENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 239,209

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.